Meanwhile diabetes treatmeant Trajenta increased 23.1% to 1.1 billion euros, and recently launched pulmonary fibrosis drug Ofev is powering ahead, with sales growing 106.4% to 600,000 euros.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...